of geranylgeranyl lipids, which in turn reduces RHO protein geranylgeranylation. 11, 12 There has been considerable support for the notion that blocking geranylgeranylation inactivates RHO proteins. 9, [13] [14] [15] [16] However, a recent study showed that knockout of GGTase-I in macrophages blocked CAAX protein geranylgeranylation and led to accumulation of GTP-bound active RHOA, RAC1, and CDC42. 17 The increased RHO protein activity led to increased RAC1, p38, and nuclear factor-κB signaling; increased reactive oxygen species; and increased proinflammatory cytokines, leading to rheumatoid arthritis in vivo. These results suggested that geranylgeranylation serves to inhibit, rather than activate, RHO proteins in macrophages and further suggested a need to reevaluate the importance of RHO protein geranylgeranylation and GGTase-I activity in other pathways and specific disease processes.
RHO proteins are involved in signaling pathways that regulate macrophage foam cell formation and cholesterol efflux, 2 processes relevant to the pathogenesis and treatment of atherosclerosis. [18] [19] [20] For example, several studies have suggested that activation of RHOA and CDC42 inhibits peroxisome proliferator-activated-γ (PPARγ) activity and cholesterol efflux in macrophages. 9, [20] [21] [22] However, most of those studies were performed by expressing dominant-negative RHO constructs or by treating cells with compounds that alter the activity of the RHO proteins or interfere with protein geranylgeranylation. Thus far, no one has used a genetic strategy to block GGTase-I activity and then define the impact of this intervention on the behavior of macrophages in vivo.
In this study, we investigated how inactivation of GGTase-I in macrophages affects the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice. We hypothesized that knockout of GGTase-I would accelerate atherosclerosis. This hypothesis was based on 3 observations. First, macrophages lacking GGTase-I mount a robust inflammatory response that would likely promote lesion development. 17, 23 Second, GGTase-I-deficient mice develop rheumatoid arthritis, 17 an inflammatory disorder associated with a high risk of atherosclerosis in humans. 24 Third, activation of RHO proteins should inhibit cholesterol efflux and stimulate foam cell formation. 9, 20, 25 
Methods

Mouse Breeding
Mice homozygous for a conditional knockout allele of the GGTase-I β subunit and heterozygous for the lysozyme M-Cre knock-in allele (Pggt1b fl/fl LC) have been described. 26 Pggt1b fl/fl LC mice were bred with LDL receptor knockout mice (Ldlr −/− ; Jackson Laboratories) and backcrossed 6 times to a C57BL/6 background. Mice were genotyped as described. 26 . Six-to 7-week-old male mice were fed a Western-type diet containing 1.25% cholesterol (Harlan AB, Sweden) for 12 and 24 weeks. Mouse experiments were approved by the local research animal ethics committee.
Preparation of En Face Aortas and Proximal Aortic Sections
Aortas were dissected to the iliac bifurcation, fixed in 4% formaldehyde, pinned out under an inverted microscope, and stained with Sudan IV as described. 28 Aortic roots were frozen in optimal cutting temperature freezing medium, and 10-µm-thick sections were stained with Oil Red O and hematoxylin. 29, 30 
Quantification of Aortic Lesions and Immunohistochemistry
En face aortas were photographed with a Sony DSC25 digital camera, and lesion areas were quantified with ImageJ software. 31 Aortic root sections were scanned in a Mirax Scanner (Zeiss, Germany), and lesions were quantified with BioPix iQ 2.1.8 software. Macrophages, smooth muscle cells, and lymphocytes in lesions were analyzed immunohistochemically with antibodies against monocyte/macrophage antibody-2 (MCA519G, Accurate, NY), α-smooth muscle actin (ab5694, Abcam), CD4, and CD8 (553043 and 553027, BD Pharmingen). Apoptotic cells in aortic root sections were analyzed with the In Situ Cell Death Detection Kit (11684809910, Roche).
Plasma Lipid and Cytokine Analyses
Plasma cholesterol and triglycerides were determined with Konelab/T Series kits and a Konelab 20 Autoanalyzer (Thermo-Fisher). Cholesterol was also measured in lipoprotein fractions of pooled plasma after fast performance liquid chromatography as described. 32 Plasma cytokines were quantified with the Mouse Proinflammatory 7-plex Ultrasensitive Kit in a Sector 2400 Imager (Meso Scale Discovery).
Generating Bone Marrow and Peritoneal Macrophages
Bone marrow cells were cultured in high-glucose Dulbecco modified Eagle medium supplemented with 10% FCS, 1% HEPES, 1% glutamine, 1% gentamycin, 0.01% β-mercaptoethanol, and 10% whole supernatant of cell line CMG14-12 as a source of monocyte colonystimulating factor. 33 Experiments were done on differentiated macrophages 7 to 10 days after plating. Intraperitoneal macrophages were collected after rinsing of the mouse peritoneal cavity with 5 mL PBS. Experiments were done 1 to 3 days after plating.
Cytokine Array
Macrophages were incubated with minimally modified LDL for 24 hours, and cytokines in the supernatant were quantified with the Mouse Cytokine Antibody Array Panel A (ARY006, R&D Biosystems).
Foam Cell Formation Assay and Quantification of Cholesterol Esters
Macrophages were seeded on glass slides in 24-well plates, incubated with 50 µg/mL acetylated LDL (acLDL) or minimally modified LDL for 24 hours, fixed with ethanol, and stained with Oil Red O as described. 31 The cells were imaged in the Mirax Scanner, and Oil Red O staining and cell area were determined with BioPix iQ 2.1.8 software. Lipid uptake was also analyzed by fluorescence-activated cell sorter analysis after cells were incubated with Alexa Fluor 488-labeled acLDL (I23380, Invitrogen) for 30 minutes at 4C and 16 hours at 37C. Cholesterol ester content in macrophages was measured 36 hours after incubation with acLDL. Neutral lipids were extracted in 2:3 n-hexane/isopropanol for 20 minutes, dried, and dissolved in 10% Triton X-100 in isopropanol. Total cholesterol and free cholesterol were determined (Wako Chemicals), and cholesterol ester content was calculated by subtracting free from total cholesterol and normalized to total cellular protein levels.
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robotic nanoflow ion source (Advion Biosciences); and ceramide and glucosylceramide were analyzed by high-performance liquid chromatography coupled to a Quattro Premier XE triple-quadrupole mass spectrometer.
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Cholesterol Efflux Assay, Apoptosis, and Cell Death Analyses
Macrophages were incubated with 1 to 2 µCi [ 3 H]cholesterol (preincubated with 50 µg/mL acLDL) in medium containing endotoxinand free fatty acid-free 0.2% BSA for 24 hours. Cholesterol pools were equilibrated overnight in medium containing 0.1% BSA. Basal and lipid acceptor-stimulated efflux was measured 6 hours after the addition of vehicle, apolipoprotein AI (10 µg/mL), or high-density lipoprotein (HDL; 100 µg/mL). Radioactivity was measured in the medium and cell lysate, and efflux was calculated as percent radioactivity in the medium relative to total radioactivity in cells and medium, normalized to total protein content. Macrophage apoptosis was detected with the ApopTag Fluorescein In Situ Apoptosis Detection Kit (S7110, Millipore), and lactate dehydrogenase in media was detected with the Cytotoxicity Detection Kit (11644793001, Roche).
Western Blotting
Cells were lysed as described. 36 GTP-bound RAC1 and CDC42 were affinity precipitated with PAK1-GST (EZ Detect Rac1 Activation Kit, Pierce), and GTP-bound RHOA was precipitated with Rhotekin-GST (RhoA Activation Biochem Kit, Cytoskeleton) as described. 17 Total lysates or affinity-precipitated proteins were resolved on 12% and 7.5% SDS-PAGE gels (Criterion and Protean, BioRad), transferred to nitrocellulose or polyvinylidene difluoride membranes, and incubated with antibodies to RAC1 (05-389, Millipore), RHOA (ARH03-B, Cytoskeleton), CDC42 (sc-2462), np-RAP1A (sc-1482, Santa Cruz Biotechnology), liver X receptor-α (LXRα; ab41902, Abcam), cyclooxygenase 2 (COX2; NB110-1948), CD36 (NB400-144), scavenger receptor class B type I (SR-B1; NB400-104), ATP-binding cassette (ABC) family members A1 (NB400-105) and G1 (ABCG1; NB400-132, Novus Biologicals), and actin (A2066, Sigma-Aldrich). Protein bands were visualized with horseradish peroxidase-conjugated secondary antibodies (sc-2354 from Santa Cruz Biotechnology and NA931 and NA934 from GE Healthcare) and the enhanced chemiluminescence Western blotting system (GE Healthcare). Band densities were analyzed with Quantity One (version 4.4.0, Bio-Rad).
PPARγ Activity Assay
Macrophages were cultured to 75% confluence on 150-mm 2 plates and incubated without monocyte colony-stimulating factor for 12 hours. Basal PPARγ activity in nuclear extracts was determined with a PPARγ activity assay kit (10006855, Cayman), and values were normalized to total nuclear protein content.
Gene Expression Analyses
RNA was isolated with the RNeasy Mini Kit (Qiagen); cDNA was synthesized with the iScript cDNA Kit (170-889, BioRad); and gene expression was analyzed by TaqMan reverse transcription-quantitative polymerase chain reaction using mouse and human probe sets for Abca1 (Mm00442646_m1, Hs01059118_m1), Abcg1 (Mm00437390_m1, Hs00245154_m1), Cox2 (m00478374_m1, Hs00153133_m1), Cd36 (Mm00432403_m1, Hs01567185_m1), Scarb1 (Mm00450234_m1, Hs00969821_m1), Pparg (Mm01184322_m1, Hs01115513_m1), and Lxra (Mm00443451_m1). Values were normalized to Gapdh (Mm4352932E, Hs402869).
Lentivirus Experiments and Inhibitors
Lentiviruses expressing short hairpin (sh) RNAs targeting mouse ABCA1 (TRCN0000271812-60), ABCG1 (TRCN0000105286-87), CD36 (TRCN000066518-22), RHOA (TRCN0000055192), RAC1 (TRCN0000304690), and SR-BI (TRCN000066573-75) were from Sigma-Aldrich; shCDC42 lentiviruses were from Santa Cruz Biotechnology (SC-29257-V). Macrophages were incubated with lentiviruses at a multiplicity of infection of 10 to 20 for 72 to 96 hours before experiments. Lentiviral construct expressing human PGGT1B gene was from SBI. Inhibitors of GGTase-I (GGTI-298), farnesyltransferase (FTI-276), COX2 (Celecoxib; PZ0008), RHO-associated protein kinase (Y-27632), and etoposide (E1383) were from Sigma; the inhibitor of P21-activated kinase (PAK18) was from Merck.
THP-1 Cells
The human acute monocytic leukemia cell line THP-1 was differentiated into macrophage-like cells with phorbol 12-myristate 13-acetate. 37 For cholesterol efflux, gene expression analyses, and Western blotting, THP-1 macrophages were incubated with a GGTI (1, 5, and 10 µmol/L) for 48 hours before experiments.
Reverse Cholesterol Transport
Bone marrow macrophages were loaded with 25 µg/mL acLDL and 5 µCi/mL [ 3 H]cholesterol for 30 hours, washed twice with PBS, scraped into RPMI-1640/0.2% BSA, spun (1000 rpm, 5 minutes, 4°C), and resuspended in RPMI-1640/0.2% BSA. Cell viability and radioactivity were counted, and 1.3×10 6 counts per minute (CPM) was injected intraperitoneally into Pggt1b▵/▵ recipient mice. Plasma samples were obtained at baseline and after 24 and 48 hours, and 5-µL aliquots were counted in a scintillation counter. Feces were collected at 0, 24, and 48 hours; soaked in distilled water (100 mg/mL) overnight at 4°C; and homogenized in an equal volume of ethanol. Then, 500-µL aliquots of the homogenate were counted in a scintillation counter. CPM/mL in the plasma and CPM/100 mg feces were expressed as percent of injected CPMs. This protocol was a modification of those used in previous studies.
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Statistics
Values are mean±SEM unless stated otherwise. Differences between groups were assessed with the t test or Mann-Whitney test and considered significant at P<0.05.
Results
Inactivating Macrophage GGTase-I Reduces Atherosclerosis but Increases Inflammation
To define the role of macrophage GGTase-I in atherogenesis, we bred mice lacking Pggt1b expression in macrophages 26 onto an Ldlr-deficient background. These mice, designated Pggt1b▵/▵, were fed a Western-type diet for 12 or 24 weeks. Atherosclerotic lesions in Pggt1b▵/▵ aortas were 50% smaller than in littermate controls at 12 weeks and 60% smaller at 24 weeks, as judged by en face analyses of the aorta ( Figure  1A ). Lesions were also reduced in aortic root sections ( Figure  IA in the online-only Data Supplement). Areas of necrosis in aortic root sections were less frequent in Pggt1b▵/▵ than in control Pggt1b +/+ mice; however, levels of apoptotic cells did not differ ( Figure IB and IC in the online-only Data Supplement). Body weight curves in Pggt1b▵/▵ and control Pggt1b +/+ mice were similar, but Pggt1b▵/▵ mice had slightly lower plasma cholesterol and triglyceride levels ( Figure 1B and 1C). The lower plasma lipid levels were also evident when the plasma lipoproteins were fractionated by fast protein liquid chromatography ( Figure 1D and Figure ID in the online-only Data Supplement).
The macrophage lesion area of aortic root sections was reduced in Pggt1b▵/▵ mice compared with controls, whereas the area of smooth muscle cells was similar in both groups of mice, as judged by immunostaining for monocyte/macrophage However, the number of T cells in lesions was 2-fold higher in Pggt1b▵/▵ mice than in controls, as judged by immunostaining for CD4 ( Figure 2C ) and CD8 (not shown). Quantification of inflammatory markers in plasma revealed increased levels of the proinflammatory cytokine CXCL1 and reduced levels of the antiinflammatory cytokine interleukin-10 in Pggt1b▵/▵ mice ( Figure 2D ). Consistent with the increased inflammatory response in vivo, cytokine production was markedly increased in Pggt1b▵/▵ intraperitoneal macrophages incubated with minimally modified LDL ( Figure 2E ). Similar results were observed in bone marrow-derived macrophages (not shown). Thus, GGTase-I-deficient macrophages are capable of robust inflammatory responses, but the Pggt1b▵/▵ mice exhibited smaller atherosclerotic lesions.
Knockout of GGTase-I Impairs Macrophage Foam Cell Formation
To determine whether GGTase-I deficiency affects lipid accumulation, we quantified Oil Red O staining in macrophages incubated for 24 hours with acLDL and minimally modified LDL. Pggt1b▵/▵ macrophages had lower levels of staining compared with Pggt1b 
GGTase-I Deficiency Increases Cholesterol Efflux by COX2-and PPARγ-Mediated Increase in SR-B1 and CD36
Pggt1b▵/▵ macrophages have normal phagocytic activity. 17 Thus, we asked whether increased lipid export might account for the reduced lipid accumulation in Pggt1b▵/▵ macrophages. For this, we loaded cells with [ 3 H]cholesterol and measured cholesterol efflux at baseline and after adding apolipoprotein AI or HDL. Basal levels of efflux in Pggt1b▵/▵ macrophages were 4-fold higher than in Pggt1b +/+ macrophages ( Figure  4A and 4B). Efflux was increased 2-fold by apolipoprotein AI and 3-fold by HDL ( Figure 4A and 4B). In keeping with these findings, cholesterol efflux was higher in Pggt1b +/+ macrophages incubated with a protein GGTI. In addition, the high levels of cholesterol efflux in Pggt1b▵/▵ macrophages could be reduced with a lentivirus expressing human PGGT1B. A protein farnesyltransferase inhibitor had no impact on To identify the pathways that mediate increased cholesterol efflux in Pggt1b▵/▵ macrophages, we quantified levels of PPARγ in nuclear extracts with an ELISA; we also assessed levels of Pparg transcripts. Basal PPARγ activity was 2-fold higher and Pparg mRNA levels were 4-fold higher in Pggt1b▵/▵ macrophages than in Pggt1b +/+ macrophages ( Figure 5A and 5B). Basal expression levels of COX2 and LXRα were also higher, as judged by mRNA levels and Western blots ( Figure  5B and 5C ). When COX2 activity in Pggt1b▵/▵ macrophages was inhibited with Celecoxib, cholesterol efflux returned to normal levels ( Figure 5D ).
Cholesterol efflux can be mediated by PPARγ-LXRα−induced upregulation of ABCA1 and ABCG1 and by COX2-PPARγ−mediated upregulation of CD36 and SR-B1. [40] [41] [42] ABCA1 and ABCG1 expression in Pggt1b▵/▵ macrophages was not different from that in Pggt1b +/+ macrophages; however, levels of SR-B1 and CD36 proteins were significantly increased ( Figure 5B and 5C ). SR-B1 levels were also higher in aortic sections from Pggt1b▵/▵ mice, as judged by immunohistochemical studies ( Figure VIA and VIB in the online-only Data Supplement).
To assess the importance of SR-B1 and CD36 in efflux of Pggt1b▵/▵ macrophages, we suppressed their expression with lentiviral shRNAs. We also suppressed expression of ABCA1 and ABCG1. In our studies, Abca1, Abcg1, Cd36, and Scarb1 transcripts were reduced by 60% to 80% ( Figure VIIA 
RHOA Activation Mediates the Increased Cholesterol Efflux in GGTase-I-Deficient Macrophages
We previously showed that GGTase-I-deficient macrophages accumulate high levels of active GTP-bound RHOA, RAC1, and CDC42, 17 and we confirmed those results in the present model ( Figure IXA in the online-only Data Supplement). To determine whether activated RHO proteins contribute to cholesterol efflux in Pggt1b▵/▵ macrophages, we suppressed their expression with lentiviral shRNA. The shRNAs reduced expression of Rhoa, Rac1, and Cdc42 transcripts by 50% to 75% ( Figure IXB in the online-only Data Supplement). Knockdown of RHOA, but not RAC1 and CDC42, reduced cholesterol efflux in Pggt1b▵/▵ macrophages to the levels observed in Pggt1b +/+ macrophages ( Figure 5E ). RHOA knockdown also reduced the expression of Cox2, Pparg, Lxra, Cd36, and Scarb1 ( Figure 5F ). Consistent with these findings, cholesterol efflux in Pggt1b▵/▵ macrophages was reduced when RHOA signaling was inhibited with a RHO kinase inhibitor. An inhibitor of RAC signaling had no effect ( Figure IXC in the online-only Data Supplement). Overall, the data suggest that RHOA activation, acting upstream of COX2, increases cholesterol efflux in Pggt1b▵/▵macrophages.
GGTase-I Deficiency Increases MacrophageStimulated Reverse Cholesterol Transport In Vivo
To determine whether the increased cholesterol efflux in Pggt1b▵/▵ macrophages results in higher levels of reverse cholesterol transport in vivo, we loaded Pggt1b +/+ and Pgg t1b▵/▵macrophages with [ 3 H]cholesterol:acLDL, injected the cells into the peritoneal cavity of Pggt1b▵/▵ mice, and measured radioactivity in plasma and feces after 24 and 48 hours. Levels of [ 3 H]cholesterol in plasma and feces were 1.5-to 2-fold higher in mice injected with Pggt1b▵/▵ macrophages than in those injected with Pggt1b +/+ macrophages ( Figure 6A and 6B) . 
Discussion
Levels of atherosclerosis in mice are generally worsened by proinflammatory factors. 23, 43 In this study, we found that GGTase-I deficiency in macrophages markedly reduces atherosclerosis despite higher levels of inflammation. GGTase-I-deficient macrophages produced high levels of proinflammatory cytokines in response to minimally modified LDL, and T-cell recruitment to subendothelial lesions was increased. The Pggt1b▵/▵ mice also develop rheumatoid arthritis, which is associated with more atherosclerotic disease in humans. 24 Thus, the lower levels of atherosclerosis in Pggt1b▵/▵ mice were surprising. Uncoupling of inflammation and lipid accumulation in atherogenesis has been observed previously, [44] [45] [46] although not to the same degree as in Pggt1b▵/▵  mice.
The finding of reduced atherosclerosis in Pggt1b▵/▵ mice is likely explained by 3 factors. First, foam cell formation in Pggt1b▵/▵ macrophages was reduced as a consequence of increased cholesterol efflux, triggered by RHOA and signaling through the COX2-PPARγ−scavenger receptor pathway. Second, the increased cholesterol efflux of Pggt1b▵/▵ macrophages resulted in increased levels of reverse cholesterol transport in Pggt1b▵/▵ mice. Third, plasma lipid levels were slightly lower in Pggt1b▵/▵ mice, likely a consequence of the increased reverse cholesterol transport. Each of these factors-more unloading of cholesterol by cultured macrophages, increased macrophage reverse cholesterol transport in vivo, and lower plasma lipid levels-would be expected, on the basis of previous studies, to reduce atherogenesis. [47] [48] [49] [50] [51] [52] The signaling pathway that led to increased cholesterol efflux of Pggt1b▵/▵ macrophages was triggered by activated RHOA, was dependent on COX2 activity, and was associated with increased expression of COX2, PPARγ, CD36, and SR-B1. RHOA was upstream in this pathway because RHOA inhibition normalized both the gene-expression changes and cholesterol efflux. Treatment with a COX2 inhibitor also normalized efflux. Knockdown experiments demonstrated that SR-B1 and CD36 were functionally involved in the increased basal and HDLstimulated cholesterol efflux in Pggt1b▵/▵ macrophages.
LXRα expression was increased in Pggt1b▵/▵ macrophages, but its targets, ABCA1 and ABCG1, were probably not involved in the increased efflux because their expression was unaffected by Pggt1b deficiency and because knockdown of those genes had no impact on cholesterol efflux. One potential explanation for why the high levels of LXRα in Pggt1b▵/▵ macrophages did not affect ABCA1 and ABCG1 expression could be an accumulation of geranylgeranyl pyrophosphate, one of the substrates for GGTase-I. Geranylgeranyl pyrophosphate and its metabolite, GGOH, block the transcriptional activity of LXRα by interfering with the interaction between LXRα and nuclear coactivators. 25, 53 The finding that ABCA1 and ABCG1 were not involved in the increased cholesterol efflux of Pggt1b▵/▵ macrophages was surprising because those transporters are considered crucial for the unloading of cholesterol from macrophages. 48, 49 However, SR-B1 and CD36 contributed to macrophage cholesterol efflux in previous studies, [40] [41] [42] and our present experiments provide strong evidence for their contribution to efflux of Pggt1b▵/▵ macrophages.
Blocking GGTase-I activity in other tissues can be associated with significant pathology 54 ; thus, our results should not prompt unbridled enthusiasm for using GGTIs in the treatment of atherosclerosis. However, they demonstrate that blocking GGTase-I activity in macrophages is atheroprotective despite local and systemic inflammation and despite the presence of severe rheumatoid arthritis. The results also shed light on mechanisms underlying pleiotropic effects of statins. Many studies, including several that assessed the impact of statins on cholesterol efflux, 9, [13] [14] [15] [16] 21, 22, 55, 56 concluded that statins and GGTIs inhibit the geranylgeranylation of RHO proteins, interfering with membrane attachment and thereby inactivating the proteins. Most of those studies were performed on the assumption that nonprenylated RHO proteins are GDP bound and inactive. But, with few exceptions, these studies did not assess the activation status of RHO proteins in statin-and GGTI-treated cells.
Our genetic experiments clearly demonstrate that nonprenylated RHO proteins are GTP bound and active in macrophages and should refine our understanding of the cellular and in vivo importance of CAAX protein geranylgeranylation. 
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